Quality of Life Analyses from the Randomized, Open-Label, Phase III PointBreak Study of Pemetrexed-Carboplatin-Bevacizumab followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non-Small-Cell Lung Cancer
Article
Spigel, David R.; Patel, Jyoti D.; Reynolds, Craig H.; Garon, Edward B.; Hermann, Robert C.; Govindan, Ramaswamy; Olsen, Mark R.; Winfree, Katherine B.; Chen, Jian; Liu, Jingyi; Guba, Susan C.; Socinski, Mark A.; Bonomi, Philip